Clinical efficacy of p16/Ki-67 dual-stained cervical cytology in secondary prevention of cervical cancer

Aleksander Celewicz; Marta Celewicz; Małgorzata Wężowska; Anita Chudecka-Głaz; Janusz Menkiszak; Elzbieta Urasińska

doi:10.5114/pjp.2018.75335

eISSN: 2084-9869
ISSN: 1233-9687

Polish Journal of Pathology

Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Open access

1/2018
vol. 69

Send email

Copy url:

abstract:

Original paper

Clinical efficacy of p16/Ki-67 dual-stained cervical cytology in secondary prevention of cervical cancer

Aleksander Celewicz

,

Marta Celewicz

,

Małgorzata Wężowska

,

Anita Chudecka-Głaz

,

Janusz Menkiszak

,

Elzbieta Urasińska

Pol J Pathol 2018; 69 (1): 42-47

DOI: https://doi.org/10.5114/pjp.2018.75335

Online publish date: 2018/05/07

View full text Get citation

PlumX metrics:

Cervical cancer is the third most common malignant neoplasm in women worldwide. HPV infection is the necessary factor for the cancer to develop. HPV DNA can be integrated into the genome of squamous epithelium and cause transcription of the viral oncoproteins and development of invasive cancer within 15-20 years. We assessed ICC co-expression of p16/Ki-67 proteins in smears collected from the uterine cervix and the association between p16/Ki-67 co-expression and cytologic and histologic results. Samples were collected from 93 women using liquid based cytology (LBC). Two microscopic slides were prepared: for Papanicolaou staining and ICC staining. Biopsy samples were collected from 43 women. Diagnosis of CIN 2+ was the endpoint of the study. p16/Ki-67 positive cells were found in women with: 1) a cytology result of ASC-US (3.59%), LSIL (2.22%), ASC-H (21.92%), HSIL (33.18%), SCC (72.22%) or NILM (3.44%); 2) a histopathologic result of CIN 1 (2.13%), CIN 2 (19.93%), CIN 3 (23.22%), SCC (69.72%) or normal histology (7.58%). p16/Ki-67 dual staining can increase the efficiency of screening methods and indicate women in whom further diagnostic procedures are required or those with extremely low risk of cancer. Sparing protocols will have a significant role in women of reproductive age.

keywords:

Clinical efficacy of p16/Ki-67 dual-stained cervical cytology in secondary prevention of cervical cancer

Aleksander Celewicz , Marta Celewicz , Małgorzata Wężowska , Anita Chudecka-Głaz , Janusz Menkiszak , Elzbieta Urasińska

cervical cancer, pap smear, cytology, p16/Ki-67, dual-stained cytology, HPV

Aleksander Celewicz

,

Marta Celewicz

,

Małgorzata Wężowska

,

Anita Chudecka-Głaz

,

Janusz Menkiszak

,

Elzbieta Urasińska